Summary
World trade was already slowing in 2019 before COVID 19 outbreak, weighed down by trade tensions and slowing economic growth, such as uncertainty generated from Brexit, the U.S.-China trade war, the Japan-South Korea trade war.
Trade is expected to fall by between 13% and 32% in 2020 as the COVID 19 pandemic disrupts normal economic activity and life around the world, according to the study of WTO.The decline in exports has been mainly due to the ongoing global slowdown, which got aggravated due to the current Covid-19 crisis. The latter resulted in large scale disruptions in supply chains and demand resulting in cancellation of orders.
Prudent Markets analysis shows that as China started reopening its economy, world exports initially recovered across the board. But estimates of the expected recovery in 2021 are uncertain, with outcomes depending largely on the duration of the outbreak and the effectiveness of the policy responses.
This research report indicated that the global Clinical Trials market was valued at USD XXX million in 2019, and it is expected to reach a value of USD XXX million by 2026, at a CAGR of XX % over the forecast period 2021-2026. In terms of the export, China occupied more than XX % export market share in 2019, India occupied XX %. XXX is the second largest region around the world, it occupied about XX % export market share in 2019. In terms of the Local Capacity, XXX is the largest region around the world, it occupied about XX % export market share in 2019.
Regional Segmentation (Value; Revenue, USD Million, 2015 - 2026) of Clinical Trials Market by Prudent Markets Include
China
EU
North America
Japan
India
Southeast Asia
South America
Middle East and Africa
Competitive Analysis; Who are the Major Players in Clinical Trials Market
Quintiles IMS
Paraxel International Corporation
Charles River Laboratories
ICON plc
SGS SA
Pharmaceutical Product Development, LLC
Wuxi AppTec Inc.
PRA Health Sciences
Chiltern International Ltd.
INC Research
...
Major Type of Clinical Trials Covered in Prudent Markets report:
Phase I
Phase II
Phase III
Phase IV
Application Segments Covered in Prudent Markets Market
Interventional
Observational
Expanded Access
For any other requirements, please feel free to contact us and we will provide you customized report.
Table of Contents
Global Clinical Trials Market 2015-2026, With Breakdown Data of Capacity, Sales, Production, Export, Import, Revenue, Price, Cost and Gross Margin
1 Market Scope
1.1 Product Details and Introduction
1.1.1 Phase I -Product Introduction and Major Manufacturers
1.1.2 Phase II -Product Introduction and Major Manufacturers
1.1.3 Phase III -Product Introduction and Major Manufacturers
1.1.4 Phase IV -Product Introduction and Major Manufacturers
1.2 Market Snapshot
1.2.1 Major Companies Overview
1.2.2 Market Concentration
1.2.3 Six-Year Compound Annual Growth Rate (CAGR)
2 Regional Market Analysis
2.1 China Clinical Trials Status and Prospect (2015-2026)
2.1.1 China Clinical Trials Market Size and Growth Rate (2015-2026)
2.1.2 China Clinical Trials Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.2 EU Clinical Trials Status and Prospect (2015-2026)
2.2.1 EU Clinical Trials Market Size and Growth Rate (2015-2026)
2.2.2 EU Clinical Trials Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.3 USA Clinical Trials Status and Prospect (2015-2026)
2.3.1 USA Clinical Trials Market Size and Growth Rate (2015-2026)
2.3.2 USA Clinical Trials Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.4 Japan Clinical Trials Status and Prospect (2015-2026)
2.4.1 Japan Clinical Trials Market Size and Growth Rate (2015-2026)
2.4.2 Japan Clinical Trials Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.5 India Clinical Trials Status and Prospect (2015-2026)
2.5.1 India Clinical Trials Market Size and Growth Rate (2015-2026)
2.5.2 India Clinical Trials Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.6 Southeast Asia Clinical Trials Status and Prospect (2015-2026)
2.6.1 Southeast Asia Clinical Trials Market Size and Growth Rate (2015-2026)
2.6.2 Southeast Asia Clinical Trials Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.7 South America Clinical Trials Status and Prospect (2015-2026)
2.7.1 South America Clinical Trials Market Size and Growth Rate (2015-2026)
2.7.2 South America Clinical Trials Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.8 Clinical Trials Status and Prospect (2015-2026)
2.8.1 Clinical Trials Market Size and Growth Rate (2015-2026)
2.8.2 Clinical Trials Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
3 Global Clinical Trials Market Assessment by Segment
3.1 Global Clinical Trials Capacity and Growth Rate
3.2 Global Clinical Trials Sales by Type
3.3 Global Clinical Trials Sales Revenue by Type
3.4 Global Clinical Trials Consumption by Application
4 Global Clinical Trials Market Assessment by Regions
4.1 Global Clinical Trials Production Analysis and Forecast by Regions (2015-2026)
4.2 Global Clinical Trials Sales Analysis and Forecast by Regions (2015-2026)
4.3 Global Clinical Trials Sales Revenue Analysis and Forecast by Regions (2015-2026)
5 Value Chain (Impact of COVID-19)
5.1 Clinical Trials Value Chain Analysis
5.1.1 Upstream
5.1.2 Downstream
5.2 COVID-19 Impact on Clinical Trials Industry
5.2.1 Industrial Policy Issued Under the Epidemic Situation
5.3 Cost-Under the Epidemic Situation
5.3.1 Cost of Raw Material
5.4 Channel Analysis
5.4.1 Distribution Channel-Under the Epidemic Situation
5.4.2 Distributors
6 Competitive Landscape
6.1 Global Clinical Trials Capacity Market Share of Manufacturers (2019-2020)
6.2 Global Clinical Trials Sales Market Share of Manufacturers (2019-2020)
6.3 Global Clinical Trials Sales Revenue Market Share of Manufacturers (2019-2020)
7 Clinical Trials Competitive Analysis
7.1 Quintiles IMS
7.1.1 Quintiles IMS Company Profiles
7.1.2 Quintiles IMS Product Introduction
7.1.3 Quintiles IMS Clinical Trials Production, Revenue (2015-2020)
7.1.4 SWOT Analysis
7.2 Paraxel International Corporation
7.2.1 Paraxel International Corporation Company Profiles
7.2.2 Paraxel International Corporation Product Introduction
7.2.3 Paraxel International Corporation Clinical Trials Production, Revenue (2015-2020)
7.2.4 SWOT Analysis
7.3 Charles River Laboratories
7.3.1 Charles River Laboratories Company Profiles
7.3.2 Charles River Laboratories Product Introduction
7.3.3 Charles River Laboratories Clinical Trials Production, Revenue (2015-2020)
7.3.4 SWOT Analysis
7.4 ICON plc
7.4.1 ICON plc Company Profiles
7.4.2 ICON plc Product Introduction
7.4.3 ICON plc Clinical Trials Production, Revenue (2015-2020)
7.4.4 SWOT Analysis
7.5 SGS SA
7.5.1 SGS SA Company Profiles
7.5.2 SGS SA Product Introduction
7.5.3 SGS SA Clinical Trials Production, Revenue (2015-2020)
7.5.4 SWOT Analysis
7.6 Pharmaceutical Product Development, LLC
7.6.1 Pharmaceutical Product Development, LLC Company Profiles
7.6.2 Pharmaceutical Product Development, LLC Product Introduction
7.6.3 Pharmaceutical Product Development, LLC Clinical Trials Production, Revenue (2015-2020)
7.6.4 SWOT Analysis
7.7 Wuxi AppTec Inc.
7.7.1 Wuxi AppTec Inc. Company Profiles
7.7.2 Wuxi AppTec Inc. Product Introduction
7.7.3 Wuxi AppTec Inc. Clinical Trials Production, Revenue (2015-2020)
7.7.4 SWOT Analysis
7.8 PRA Health Sciences
7.8.1 PRA Health Sciences Company Profiles
7.8.2 PRA Health Sciences Product Introduction
7.8.3 PRA Health Sciences Clinical Trials Production, Revenue (2015-2020)
7.8.4 SWOT Analysis
7.9 Chiltern International Ltd.
7.9.1 Chiltern International Ltd. Company Profiles
7.9.2 Chiltern International Ltd. Product Introduction
7.9.3 Chiltern International Ltd. Clinical Trials Production, Revenue (2015-2020)
7.9.4 SWOT Analysis
7.10 INC Research
7.10.1 INC Research Company Profiles
7.10.2 INC Research Product Introduction
7.10.3 INC Research Clinical Trials Production, Revenue (2015-2020)
7.10.4 SWOT Analysis
8 Conclusion